Hong AR, Lee J, Ku EJ et al (2015) Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): a randomized trial
The Fear of Regain: When people stop taking GLP-1s, the "food noise" often returns, leading to weight regain and a loss of healthy habits
The market is driven by the expanding clinical indication of these therapies, which are now evolving from handling Type 2 diabetes to long-term chronic weight management and even cardiovascular risk reduction
139 MomcilovicM.BaileyS
Malate then exits the mitochondria and is converted by cytosolic malic enzyme 1 (ME1) into nicotinamide adenine dinucleotide phosphate (NADPH) and pyruvate, with the latter serving as a precursor for lactate synthesis
It keeps our brain safe from all sorts of substances, chemicals and bacteria, Trapp says